LaserFocusWorld | April 1, 2019: Not only can targeted near-infrared light kill cancer, but it can facilitate the growth of healthy cells to replace cancerous cells, boosting the photoimmune response of the body.
In the process of developing imaging probes and near-infrared (near-IR) fluorophores to aid in the identification of cancerous tumors, senior investigator in the Molecular Imaging Program at the National Cancer Institute/National Institutes of Health (NIH; Bethesda, MD) and leader of the Laboratory of Molecular Theranostics (LMT) Hisataka Kobayashi and LMT colleagues discovered a new dye (IRDye700DX) that is highly lethal to cancer cells when conjugated to an antibody.
